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Abstract Myalgic encephalomyelitis (ME) is a complex, het-
erogeneous illness of unknown etiology. The search for bio-
markers that can delineate cases from controls is one of the
most active areas of ME research; however, little progress has
been made in achieving this goal. In contrast to identifying
biomarkers that are directly involved in the pathological pro-
cess, an immunosignature identifies antibodies raised to pro-
teins expressed during, and potentially involved in, the path-
ological process. Although these proteins might be unknown,
it is possible to detect antibodies that react to these proteins
using random peptide arrays. In the present study, we probe a
custom 125,000 random 12-mer peptide microarray with sera
from 21 ME cases and 21 controls from the USA and Europe
and used these data to develop a diagnostic signature. We
further used these peptide sequences to potentially uncover
the naturally occurring candidate antigens to which these an-
tibodies may specifically react with in vivo. Our analysis
revealed a subset of 25 peptides that distinguished cases and
controls with high specificity and sensitivity. Additionally,
Basic Local Alignment Search Tool (BLAST) searches sug-
gest that these peptides primarily represent human self-
antigens and endogenous retroviral sequences and, to a minor
extent, viral and bacterial pathogens.
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Introduction
Myalgic encephalomyelitis (ME), also commonly referred to
as chronic fatigue syndrome or ME/CFS, is a heterogeneous
illness characterized by a number of physical symptoms and
comorbid conditions including neurocognitive dysfunction,
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